Skip to content
KFF Health News KFF Health News KFF Health News KFF Health News
Donate
  • Donate
  • Connect With Us:
  • Contact
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS
  • Trump 2.0
    • Agency Watch
    • Medicaid Watch
    • State Watch
    • Rural Health Payout
  • Public Health
  • Race & Health
  • Audio
    • KFF Health News Minute
    • What the Health?
    • Health Care Helpline
    • An Arm and a Leg
    • Silence in Sikeston
    • Epidemic
  • Investigations
    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Dead Zone
    • Deadly Denials
    • Diagnosis: Debt
    • Guns, Race, and Profit
    • Overpayment Outrage
    • Payback: Tracking Opioid Cash
    • Priced Out
    • ALL INVESTIGATIONS
  • More Topics
    • Abortion
    • Aging
    • Climate
    • COVID-19
    • Health Care Costs
    • Insurance
    • Medicaid
    • Medicare
    • Mental Health
    • Pharma
    • Rural Health
    • Uninsured

Search Results

Filter Results

Date
Custom Date Range
Topic
Content Type

Showing 8041-8060 of 131,622 results

A photo of Senator Ron Wyden speaking into reporters' microphones at the Senate subway station inside the U.S. Capitol.

‘Until It Is Fixed’: Congress Ramps Up Action on Social Security Clawbacks

By David Hilzenrath and Jodie Fleischer, Cox Media Group December 15, 2023 KFF Health News Original

Sen. Ron Wyden (D-Ore.), chair of the Senate Finance Committee, vowed to meet monthly with Social Security officials until the problems surrounding overpayment demands are fixed.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

What the Health? From KFF Health News: Abortion and SCOTUS, Together Again

December 14, 2023 Podcast

The Supreme Court agreed this week to hear its first major case on abortion since overturning Roe v. Wade — one that could restrict the availability of the abortion pill mifepristone, even in states where abortion remains legal. Meanwhile, on Capitol Hill, lawmakers in the House and Senate finally moved to renew health programs that expired in October — but it’s likely too late to finish the job in 2023. Alice Miranda Ollstein of Politico, Riley Griffin of Bloomberg News, and Lauren Weber of The Washington Post join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Jen Golbeck, a University of Maryland professor and social media superstar, about her new book, “The Purest Bond,” which lays out the science of the human-canine relationship.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

WHO Advisory Group Says Keep Using Single-Variant Shots Against Covid

December 14, 2023 Morning Briefing

A WHO technical advisory group suggested, in the light of current genetic changes in the covid virus, vaccination programs should stay with the current monovalent covid shot that targets the XBB.1.5 variant. Separately, Pfizer’s share price fell after it said fewer covid shots would be sold next year.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Research Roundup: C. Diff; Long Covid; Semaglutide; Daydreaming

December 14, 2023 Morning Briefing

Each week, KFF Health News compiles a selection of health policy studies and briefs.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Poison Centers Report 1,500% Spike In Calls Related To Weight-Loss Drug

December 14, 2023 Morning Briefing

So far this year, America’s poison control centers reported nearly 3,000 calls involving semaglutide — the medication sold as Ozempic and Wegovy. Callers report symptoms such as nausea, vomiting, and constipation and some have been hospitalized for accidental overdoses.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Americans Have More Physical, Mental Health Woes Now Than Before Covid

December 14, 2023 Morning Briefing

New Gallup data show more Americans had diabetes diagnoses, and other health issues, and also lower confidence than compared to before the pandemic. Meanwhile, a new report from actuary firm Milliman shows about 2 in 3 Americans with mental health conditions couldn’t access treatment.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

New Yorkers’ Credit Reports Will No Longer Reflect Medical Debt

December 14, 2023 Morning Briefing

New York Gov. Kathy Hochul signed a law that prohibits credit agencies from collecting information about medical debt and using it in credit reports. Other state health news relates to transgender health, kratom, reproductive health, and other issues.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Scientists May Have Found Cause Of Severe Morning Sickness

December 14, 2023 Morning Briefing

The discovery suggests that a single hormone — GDF15 — plays a role in causing hyperemesis gravidum, meaning a possible route to new treatments has been uncovered. Also in the news: more lead poisoning from applesauce pouches; the Air Force embraces smartwatches for health; and more.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Morning Briefing for Thursday, December 14, 2023

December 14, 2023 Morning Briefing

U.S. health care spending, abortion pill access, AI, medical debt, weight-loss drug overdoses, covid shots, morning sickness, and more are in the news.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

House Bill Lets Schools Serve Whole Milk, Reversing 2012 Low-Fat Push

December 14, 2023 Morning Briefing

The “Whole Milk for Healthy Kids Act,” which would allow the National School Lunch Program to serve whole milk, passed 330-99 in the House on Wednesday. In 2012, then-First Lady Michelle Obama moved to only allow low-fat variations to be offered to school kids.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Americans Spent $4.5 Trillion On Health Care In 2022

December 14, 2023 Morning Briefing

News outlets cover a new federal analysis of health expenditures that have been bouncing around during the pandemic but now stand at nearly $13,500 annually per person. Axios suggests the rise in spending in 2022 shows a return to pre-pandemic patterns of spending growth. But other data show fewer people have gone uninsured over the last three years.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Supreme Court Will Hear Case Challenging Abortion Pill Access

December 14, 2023 Morning Briefing

After a panel of the United States Court of Appeals for the Fifth Circuit earlier suggested that access to mifepristone should be curbed, despite the FDA’s regulations for the pill, the Biden administration asked the justices to intervene. Mifepristone combined with misoprostol is currently the most common medicated abortion protocol in the U.S.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

HHS Finalizes Tech Rule To Increase AI Transparency In Health IT Software

December 14, 2023 Morning Briefing

Vendors that want to certify their AI-enabled health IT products through HHS’ Office of the National Coordinator for Health Information Technology now must disclose how their algorithm was designed, developed, and trained.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Viewpoints: Banning Mifepristone Undermines FDA Authority; Abortion Ban Exemptions Are A Farce

December 14, 2023 Morning Briefing

Editorial writers delve into abortion rights, diabetes, obesity and long covid.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

First Edition: Dec. 14, 2023

December 14, 2023 Morning Briefing

Today’s early morning highlights from the major news organizations.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
A photo of an N95 mask.

Rift Over When to Use N95s Puts Health Workers at Risk Again

By Amy Maxmen December 14, 2023 KFF Health News Original

The Centers for Disease Control and Prevention is considering fuzzy guidelines on infection control in hospitals, critics say, leaving employers free to cut corners on N95 masks and other protective measures.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

An Arm and a Leg: When Hospitals Sue Patients (Part 1)

By Dan Weissmann December 14, 2023 Podcast

Some hospitals sue patients over unpaid medical bills. But is this even an effective way for hospitals to recoup lost revenue? On this episode of “An Arm and a Leg,” host Dan Weissmann speaks with medical-debt experts to explore a different solution.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Republicans Once Championed Public Health. What Happened?

By Julie Rovner December 13, 2023 KFF Health News Original

It wasn’t that long ago that Republicans were all-in on boosting public health spending. “The highest investment priority in Washington should be to double the federal budget for scientific research,” former House Speaker Newt Gingrich (R-Ga.) wrote in a 1999 op-ed in The Washington Post. Big spending increases for the National Institutes of Health soon […]

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Eisai’s Alzheimer’s Drug To Launch In Japan For 25% Less Than US Price

December 13, 2023 Morning Briefing

Leqembi is set to be available from Dec. 20, with intravenous treatment expected to cost about $20,500 per patient yearly, compared to $26,000-plus in the U.S. Also in Japan, officials reported the country’s first fatality from mpox.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

New Combination Antibiotic On The Horizon; Early Drug Therapy May Halt HIV Progression In Babies

December 13, 2023 Morning Briefing

Read recent pharmaceutical developments in KFF Health News’ Prescription Drug Watch roundup.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
  • Previous
  • 401
  • 402
  • 403
  • 404
  • 405
  • Next

More From KFF Health News

Many ACA Customers Are Paying Higher Premiums. Most Blame Trump and Republicans, Poll Finds.

What the Health? From KFF Health News: RFK Jr.’s Vaccine Schedule Changes Blocked — For Now

A photo of Mehmet Oz speaking at a podium at the White House. American flags are seen behind him.

Oz Says California’s Not Fighting Health Care Fraud, but Data Shows It’s Part of a Larger Battle

Lawmakers Seek To Protect Crisis Pregnancy Centers as Abortion Clinic Numbers Shrink

KFF

© 2026 KFF. All rights reserved.

  • About Us
  • Donate
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Staff
  • Republish Our Content
  • Email Sign-Up
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS

Powered by WordPress VIP

Thank you for your interest in supporting KFF Health News, the nation’s leading nonprofit newsroom focused on health and health policy. We distribute our journalism for free and without advertising through media partners of all sizes and in communities large and small. We appreciate all forms of engagement from our readers and listeners, and welcome your support.

KHN is an editorially independent program of KFF (Kaiser Family Foundation). You can support KHN by making a contribution to KFF, a non-profit charitable organization that is not associated with Kaiser Permanente.

Click the button below to go to KFF’s donation page which will provide more information and FAQs. Thank you!

Continue